Skip to main content

Nasdaq Stocks

AVIR Crosses Above Average Analyst Target

5 years 9 months ago
In recent trading, shares of Atea Pharmaceuticals Inc (Symbol: AVIR) have crossed above the average analyst 12-month target price of $51.33, changing hands for $52.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad

AeroVironment Reaches Analyst Target Price

5 years 9 months ago
In recent trading, shares of AeroVironment, Inc. (Symbol: AVAV) have crossed above the average analyst 12-month target price of $96.33, changing hands for $125.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

JetBlue Airways Reaches Analyst Target Price

5 years 9 months ago
In recent trading, shares of JetBlue Airways Corp (Symbol: JBLU) have crossed above the average analyst 12-month target price of $15.46, changing hands for $15.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

MasTec Vulnerable For Downside Risk At $77?

5 years 9 months ago
After a solid 3x rise since the March 23 levels of last year, at the current price of around $77 per share we believe MasTec Inc. stock (NYSE: MTZ), an infrastructure and construction company, has reached its near-term potential. MTZ stock has rallied from $26 to $77, significa

Time To Exit Motorola Solutions Stock?

5 years 9 months ago
Up 40% since March, we believe Motorola Solutions stock (NYSE: MSI) has potential downside of around 15% from its current levels. The company sells data communication and telecommunication equipment and its stock trades at $174 currently, around 5% higher than the level it was

Baxter Is A Better Choice Than Boston Scientific Stock

5 years 9 months ago
We think that Baxter International (NYSE: BAX) currently is a better pick compared to Boston Scientific (NYSE: BSX). BAX stock trades at about 3.6x trailing Revenues, compared to around 5.2x for Boston Scientific. Does this gap in Baxter’s valuation make se

Should You Buy Hexcel At $48?

5 years 9 months ago
We believe that Hexcel stock (NYSE: HXL), an industrial materials company that manufactures structural materials for use in aerospace, defense, and industrial markets, is a good buying opportunity at the present time. HXL stock trades near $48 currently and it is, in fact, down

What's Happening With Novavax Stock?

5 years 9 months ago
Vaccine developer Novavax (NASDAQ: NVAX) is seen as a key player in the Coronavirus vaccine space. Here’s a quick overview of what has been happening with the company over the last few weeks. Firstly, Novavax initiated a phase 3 study for its Covid-19 vaccine candidate in

Why Qorvo Stock's Rally Isn't Done Yet

5 years 9 months ago
Qorvo (NASDAQ: QRVO), a semiconductor vendor best known for supplying radio frequency (RF) components had a solid 2020, with its stock price rising by about 60% through the year. The stock is also up almost 3x since the end of 2018 and now trades at about $182 per share. The re

What's Next For Arvinas After A Solid 2x Increase?

5 years 9 months ago
After a solid 2x rise since the March 23 levels of last year, at the current price of around $82 per share we believe Arvinas stock (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments based on targeted protein degradation, has reached its near-term poten

Elanco A Better Choice Than Zoetis?

5 years 9 months ago
We think that Elanco Animal Health (NYSE: ELAN) currently is a better pick compared to Zoetis (NYSE: ZTS). ELAN stock trades at about 5x trailing Revenues, compared to around 12x for Zoetis. Does this gap in Elanco’s valuation make sense? We don’t thi
Checked
29 minutes 32 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed